SynthesisEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2025
Hypoalbuminemia associated perioperative mortality, reoperation, and readmission rates among total joint arthroplasty procedures: a systematic review and meta-analysis.
Synthesis in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Modifiable pre-operative physiological predictors of length of stay following shoulder arthroplasty: a systematic review.JSES reviews, reports, and techniques · 2026Review
- Prognostic Significance of Preoperative Albumin and Prealbumin in Predicting Adverse Events After Posterior Lumbar Interbody Fusion in Elderly Patients.Clinical interventions in aging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlbumin had consistently demonstrated an association with readmission, reoperation and mortality rates among total joint arthroplasty (TJA) patients. The currently literature demonstrates variable effect sizes of hypoalbuminemia and postoperative outcomes.
methodsPubMed/MEDLINE, Embase, Ovid, CENTRAL, the trial register, and Scopus were searched. Associations between preoperative albumin and postoperative readmission, reoperation, and mortality among TJA patients were determined. Zero-event rates were included with the Freeman-Tukey and study heterogeneity > 50% was accounted for with a random-effects model Subgroup analyses were conducted for total shoulder (TSA), knee (TKA), and hip arthroplasty (THA).
resultsTwenty-one eligible studies with 605,942 patients were included. Hypoalbuminemia reported a 1.99, 2.20, and 3.93 -fold increased odds of readmission (OR 1.99, 95% CI 1.66-2.39; p < 0.001), reoperation (OR 2.20, 95% CI 1.73-2.81; p < 0.001) and mortality (OR 3.93, 95% CI 2.56-6.05; p < 0.001), with significant respective heterogeneity of I2 = 90%, 78% and 95%. On subgroup analysis, hypoalbuminemia respectively exhibited 1.30 (OR 1.30, 95% CI 1.19-1.42; p < 0.001), 2.01 (OR 2.01, 95% CI 1.62-2.50; p < 0.001) and 1.88 (OR 1.88, 95% CI 0.58-6.12; p = 0.29) times increased odds of readmission for THA, TKA and TSA, respectively exhibited 1.70 (OR 1.70, 95% CI 1.22-2.38 p = 0.002), 2.67 (OR 2.67, 95% CI 1.38-5.16; p = 0.003) and 3.60 (OR 3.60, 95% CI 1.84-7.03; p = 0.0002) times increased odds of reoperation for THA, TKA and TSA,, and respectively exhibited 6.06 (OR 6.06, 95% CI 2.05-17.90; p = 0.001), 3.96 (OR 3.96, 95% CI 1.78-8.83; p = 0.0008) and 14.21 (OR 14.57, 95% CI 2.10-101.14; p = 0.007) times increased odds of mortality for THA, TKA and TSA.
conclusionAlthough serum albumin predicts post-TJA readmission, reoperation and mortality, the large variation in risk requires investigation of procedure and population specific thresholds for hypoalbuminemia.
Indexed as
Identifiers
40781178What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.